Form 4/A for BCPC BALCHEM CORP
Accepted 2025-04-11 00:00:00 ET · period of report 2025-02-12 · accession 0001140361-25-013550 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2025-04-11 | 2025-02-12 | BCPC | Boned Frederic | SVP, GM, Human Nutri, Health | A - Grant | $0.00 | +1,580 | 6,730 | +31% | $0 |
| DA | 2025-04-11 | 2025-02-12 | BCPC | Boned Frederic | SVP, GM, Human Nutri, Health | A - Grant | $0.00 | +5,200 | 5,200 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | A | A | 1,580 | $0.00 | 6,730 | D | — | — | (F1) Ownership of restricted stock vests in Reporting Person ratably over a 3 year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. |
| 2 | Derivative | Stock Option | 2025-02-12 | A | A | 5,200 | $0.00 | 5,200 | D | $159.18 · — to 2035-02-12 | 5,200 Common Stock | (F2) Options vest 20% Year 1; 40% Year 2: and 40% Year 3. |